STOCK TITAN

Ceribell: Innovation ACP Trust sells 25,000 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Ceribell, Inc. (CBLL) director Josef Parvizi reported that the Innovation ACP Trust sold 25,000 common shares on November 16, 2026, at a weighted average price of $26.02 per share. The shares were sold in multiple transactions at prices ranging from $25.60 to $26.41. The sale was made under a Rule 10b5-1 trading plan adopted August 12, 2026. Afterward, the Innovation ACP Trust held 882,911 shares. Parvizi also reported 23,284 shares held directly, 707,206 through the Josef Parvizi Trust, and 369,088 through the ACP 2021 Trust. He disclaimed beneficial ownership of the trust-held securities except to the extent of his pecuniary interest.

Insider Parvizi Josef
Role Director
Sold 25,000 shs ($651K)
Type Security Shares Price Value
Sale Common Stock F6, F1, F2, F3 25,000 $26.02 $651K
Holding Common Stock -- -- --
Holding Common Stock F2, F4 -- -- --
Holding Common Stock F2, F5 -- -- --
Holdings After Transaction: Common Stock — 882,911 shares (Indirect, By Innovation ACP Trust); Common Stock — 23,284 shares (Direct); Common Stock — 707,206 shares (Indirect, By Josef Parvizi Trust); Common Stock — 369,088 shares (Indirect, By ACP 2021 Trust)
Footnotes (6)
  1. F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.6 to $26.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.
  2. F2. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
  3. F3. The Reporting Person is a co-trustee of the Innovation ACP Trust, and therefore may be deemed to share beneficial ownership of these securities.
  4. F4. The Reporting Person is the sole trustee of the Josef Parvizi Trust, and therefore may be deemed to have beneficial ownership of these securities.
  5. F5. The Reporting Person is a co-trustee of the ACP 2021 Trust, and therefore may be deemed to share beneficial ownership of these securities.
  6. F6. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 12, 2026.
Shares sold 25,000 shares Innovation ACP Trust sale on November 16, 2026
Weighted average sale price $26.02 per share Innovation ACP Trust sale on November 16, 2026
Execution price range $25.60–$26.41 per share Prices for the multiple sale transactions, inclusive
Innovation ACP Trust shares held after sale 882,911 shares Reported following the November 16, 2026 sale
Direct shares held 23,284 shares Reported following the November 16, 2026 sale
Josef Parvizi Trust shares held 707,206 shares Indirect holding reported following the sale
ACP 2021 Trust shares held 369,088 shares Indirect holding reported following the sale
Trading plan adoption date August 12, 2026 Rule 10b5-1 plan associated with the transactions
Rule 10b5-1 trading plan regulatory
"transactions were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
pecuniary interest regulatory
"except to the extent of his pecuniary interest therein"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CBLL shares did the Innovation ACP Trust sell, and at what price?

The Innovation ACP Trust sold 25,000 Ceribell common shares on November 16, 2026, at a weighted average price of $26.02 per share. The shares were sold in multiple transactions at prices ranging from $25.60 to $26.41, inclusive.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Parvizi Josef

(Last)(First)(Middle)
C/O CERIBELL, INC.
360 N. PASTORIA AVENUE

(Street)
SUNNYVALE CALIFORNIA 94085

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Ceribell, Inc. [ CBLL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/16/2026S(6)25,000D$26.02(1)882,911IBy Innovation ACP Trust(2)(3)
Common Stock23,284D
Common Stock707,206IBy Josef Parvizi Trust(2)(4)
Common Stock369,088IBy ACP 2021 Trust(2)(5)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.6 to $26.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.
2. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
3. The Reporting Person is a co-trustee of the Innovation ACP Trust, and therefore may be deemed to share beneficial ownership of these securities.
4. The Reporting Person is the sole trustee of the Josef Parvizi Trust, and therefore may be deemed to have beneficial ownership of these securities.
5. The Reporting Person is a co-trustee of the ACP 2021 Trust, and therefore may be deemed to share beneficial ownership of these securities.
6. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 12, 2026.
Remarks:
Exhibit 24.1 - Power of Attorney
/s/ Jessica Puathasnanon, Attorney-in-Fact for Josef Parvizi11/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading